World Bulletin / News Desk
People using a common class of antidepressants may have slightly increased odds of suffering bleeding in the brain - though the risk is still very small, according to a Canadian study looking at more than 500,000 people.
The antidepressants are known as selective serotonin reuptake inhibitors (SSRIs) and include widely used drugs like fluoxetine (Prozac), sertraline (Zoloft), citalopram (Celexa) and paroxetine (Paxil.)
The SSRIs have been linked to a risk of stomach bleeding, but studies have come to conflicting findings on whether SSRI users have any higher risk of hemorrhagic strokes, which happen when there is bleeding in or around the brain.
For the study, which appeared in the journal Neurology, researchers pooled the findings from 16 past studies involving more than 500,000 people who were on SSRIs or not.
Overall, antidepressant users were about 40 to 50 percent more likely to suffer bleeding in or around the brain.
But while those numbers might sound big, the risks to any one person would be "extremely low," said lead researcher Daniel Hackam, an associate professor of medicine at Western University in London, Ontario, Canada.
Based on these figures, he said, there would be one brain hemorrhage for every 10,000 people using an SSRI over one year.
What's more, the findings do not prove that the antidepressants directly cause brain bleeds. It's possible, Hackham said, that SSRI users are "sicker" than non-users or have habits that put them at greater stroke risk.
The researchers tried to account for those factors in their calculations, but some of the studies they analyzed lacked key information, such as peoples's smoking and drinking habits, and whether they had diabetes.
"We can't infer cause and effect from this," Hackam said.
On the other hand, there are reasons to believe it's the medications themselves. For one, the hemorrhage risk seemed greatest in the first months after people started using an SSRI.
There's also a biological argument. SSRIs seem to make it harder for blood cells called platelets to clump together and form clots - and there can be a big drop in a person's platelet functions in the first weeks after starting an SSRI, he said.
Still, he stressed that people on the antidepressants should not be alarmed.
"I think that overall, these medications are quite safe," he added.
But people who are already at increased risk of a brain hemorrhage may need to be careful. That includes people who have had a brain bleed in the past, or are on medications that reduce blood clotting.
The worst Ebola outbreak in history has infected more than 3,000 people and killed some 1,550 since it was first detected early this year, U.S. health officials predict the number of Ebola cases will keep rising in the next two weeks.
Solar and wind's share in electricity production from renewable sources rose globally, share of hydro dropped in 2013, according to International Energy Agency report.
The fragile reef, which stretches 2,300 km (1,430 miles) along Australia's east coast was the centrepiece of a campaign by green groups and tour operators opposing the plan
World Bank President Jim Yong Kim said Western healthcare facilities would easily be able to contain the disease, and urged wealthy nations to share the knowledge and resources to help African countries tackle it.
Saudi Deputy Labor Minister Mufraj bin Saad al-Haqbani said the decision was temporary.
The World Health Organization has announced that the Ebola virus has killed some 1,552 people in West Africa, mostly in Liberia, Guinea and Sierra Leone, since the outbreak began in January.
UN deputy secretary general Jan Eliasson said the failure to address the issue of sanitation would prove “disastrous.”
The Ebola outbreak in West Africa has taken 1,552 lives out of 3,069 known cases in four countries and "continues to accelerate", WHO said
Presidential Press Secretary Jerolinmek Piah told AA the names would be announced later.
The WHO urged a range of "regulatory options", including prohibiting e-cigarette makers from making health claims
The doctor died after receiving the experimental drug ZMapp.
Japan has received inquiries from some countries on the influenza drug favipiravir, or T-705 as it is known in the developmental code.
Some 54 people have died in or near the capital Accra, and around 300 people are now being infected daily with the highly contagious disease, putting pressure on local health facilities, said Linda Van-Otoo, GHS director for Greater Accra.
A Philippine seaman is being monitored in Togo for signs of the disease but authorities say the country is still Ebola-free, despite dozens of workers returning from Liberia.
A 36-year-old man from Senegal is being tested in Barcelona.
MSF (Doctors Without Borders) has deployed 1,000 of its own staff in the stricken region, running centres that currently have 300 beds